After a stellar FY24 performance, Natco Pharma’s stock has taken a hit. What’s next for the company as it faces crucial ...

Delhi HC upholds Novartis’s patent on Ceritinib, rejecting Natco’s claims of invalidity. Explore the court's reasoning on ...

Natco Pharma Ltd is quoting at Rs 1479.3, up 2.32% on the day as on 12:49 IST on the NSE. The stock is up 93.42% in last one year as compared to a 13.26% jump in NIFTY and a 40.33% jump in the Nifty ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Nifty Pharma, the sole gainer among sectoral indices, was up 1.8 per cent, as compared to 1 per cent decline in the Nifty 50.

An order prohibiting six local companies—Natco Pharma, Hetero, BDR Pharma, Shilpa Medicare, Alkem, and Laurus Labs—from marketing generic versions was recently passed by the Delhi High Court.

Benchmark NSE Nifty50 index ended down 364.21 points at 23587.5, while the BSE Sensex stood 1176.46 points at 78041.59. Among ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN ...

Microsoft has acquired a 121,000 sq yard land parcel near Hyderabad for ₹181.25 crore from Natco Pharma, adding to its ...

Microsoft India has bought a land parcel in Mekaguda town near Hyderabad from Natco Pharma Limited and Time Cap Pharma Labs ...

AM(IST)on Friday in a weak market. Dr. Reddy's Laboratories Ltd.(up 2.37 per cent), Aurobindo Pharma Ltd.(up 1.32 per cent) ...